Status:
COMPLETED
Testing Latest Version of NidekRS3000Adv
Lead Sponsor:
Doheny Image Reading Center
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Brief Summary
The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these ch...
Eligibility Criteria
Inclusion
- Healthy participants
- 18 years old or older
Exclusion
- Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging
- subjects who are unable to maintain retinal fixation on a specified target
- subjects unable to achieve sufficient pupil dilation and alignment stability for imaging to take place
- subjects with media opacity which preclude high quality imaging will be excluded.
- vulnerable subjects
- subjects under 18
- pregnant subjects
- economically and educationally disadvantaged subjects
- decision impaired subjects
- homeless subjects
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 28 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03318705
Start Date
February 1 2018
End Date
March 28 2018
Last Update
July 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Doheny Eye Centers UCLA
Pasadena, California, United States, 91105